Workspace / Research/MAXHEALTH
Prices to 11 Sept 2026 · Financials to 30 Jun 2026 · Developments 13 Sept 2026
Company research / Focus view

Max Healthcare Institute

MAXHEALTH · Pharma & Healthcare · large cap · Nifty 50

Revenue · FY26
₹8,225 cr
+19.0% YoY

What the business sold

Net profit · FY26
₹1,442 cr
+34.1% YoY

What it kept after tax

Operating profit · FY26
₹1,877 cr
+19.1% YoY

Profit from operations

Operating cash flow · FY26
₹1,633 cr
+13.6% YoY

Cash the operations produced

Total debt · FY26
₹3,478 cr
+15.5% YoY

Borrowings against the business

Dividend per share · FY26

Paid out per share · not collected yet

Five years in perspective

Price index · Start = 100 · Dividends excluded · ₹1,037.7 today (-0.09%)

+172.0% · 5Y
2021 · 10020222023202420252026 · 313.2
1M -0.2%6M +0.5%1Y -12.0%3Y +66.8%5Y +172.0%
Market cap
₹1.01 L Cr

As of 13 Sept 2026

Price to earnings
69.5

Price to book 9.4

Dividend yield
19.00%

Trailing twelve months

52-week range
₹903 – ₹1,222

Closing prices

Sign in to see the full financial record and classified developments

Guests see a sample. Members get every company, five-year fundamentals, classified developments, a watchlist and the decision journal.

Sign in with Google